Results 151 to 160 of about 28,157 (212)

Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster [PDF]

, 2023
Julien Favresse, Constant Gillot, Mélanie Closset, Julien Cabo, Loris Wauthier, Clara David, Marc Elsen, Jean‐Michel Dogné, Jonathan Douxfils   +8 more
openalex   +1 more source

Frosted branch angiitis after booster vaccination with BNT162b2

Journal Français d'Ophtalmologie, 2023
Haas, A.-M., Stattin, M., Barisani-Asenbauer, T., Krepler, K., Ansari-Shahrezaei, S.   +4 more
openaire   +2 more sources

mRNA-based SARS-CoV-2 vaccines: intracellular processing and aggregation of the encoded spike protein as a mechanistic contributor to cardiac cellular stress. [PDF]

Front Immunol
Schreckenberg R, Woitasky N, Itani N, Czech L, Windhorst AC, Juchem M, Bär C, Thum T, Ferdinandy P, Schulz R.   +9 more
europepmc   +1 more source

Antibodies against Receptor Binding Domain of SARS-CoV-2 spike protein induced by BNT162b2 vaccine: results from a pragmatic, real-life study

, 2021
Marcello Mariani, Maura Acquila, Gino Tripodi, Raffaele Spiazzi, Elio Castagnola   +4 more
openalex   +1 more source

Immune Response to COVID-19 Vaccines: Updates in a Fast-Moving Scenario. [PDF]

Vaccines (Basel)
De Marco F.
europepmc   +1 more source

Acquired Pure Red Cell Aplasia Following BNT162b2 mRNA COVID-19 Vaccination. [PDF]

Intern Med
Hayase N, Kaneda Y, Fukuno K, Kanemura N.   +3 more
europepmc   +1 more source

Factors influencing Anti-SARS-CoV-2 IgG levels after vaccination in breast cancer patients. [PDF]

Discov Oncol
Shueng PW, Ting WC, Chang CC, Chang WW, Tseng YJ, Chang CF, Chen GD.   +6 more
europepmc   +1 more source

Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform. [PDF]

PLoS One
Volkman HR, de Munter L, Nguyen JL, Tran TMP, Mitratza M, Marques C, Choi L, Valluri S, Yang J, Antón A, Casas I, Conde-Sousa E, Drikite L, Grüner B, Icardi G, Ten Kate GL, Martin C, Mira-Iglesias A, Orrico-Sánchez A, Otero-Romero S, Rohde G, Jodar L, McLaughlin JM, Bollaerts K.   +23 more
europepmc   +1 more source

Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents

Qiong Wu, Bingyu Zhang, Jiayi Tong, L. Charles Bailey, H. Timothy Bunnell, Jiajie Chen, Elizabeth A. Chrischilles, Dimitri Christakis, Stephen M. Downs, Kathryn Hirabayashi, Aaron Mishkin, Abu Saleh Mohammad Mosa, Nathan M. Pajor, Suchitra Rao, Hanieh Razzaghi, Hayden T. Schwenk, Marion R. Sills, Huiyuan Wang, Linbo Wang, Yudong Wang, Dazheng Zhang, Ting Zhou, Ravi Jhaveri, Eric J. Tchetgen Tchetgen, Jeffrey S. Morris, Christopher B. Forrest, Yong Chen   +26 more
openalex   +1 more source

Correction: Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination. [PDF]

PLoS Pathog
PLOS Pathogens Editors.
europepmc   +1 more source